A detailed history of Tower Research Capital LLC (Trc) transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,971 shares of LXRX stock, worth $4,239. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,971
Previous 16,952 64.78%
Holding current value
$4,239
Previous $28,000 67.86%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.51 - $2.39 $16,581 - $26,244
-10,981 Reduced 64.78%
5,971 $9,000
Q2 2024

Aug 13, 2024

SELL
$1.54 - $2.28 $1,670 - $2,473
-1,085 Reduced 6.02%
16,952 $28,000
Q1 2024

May 15, 2024

BUY
$1.3 - $3.58 $2,750 - $7,575
2,116 Added 13.29%
18,037 $43,000
Q4 2023

Feb 13, 2024

SELL
$1.0 - $1.53 $1,009 - $1,543
-1,009 Reduced 5.96%
15,921 $24,000
Q3 2023

Nov 14, 2023

SELL
$1.06 - $2.33 $29,306 - $64,419
-27,648 Reduced 62.02%
16,930 $18,000
Q2 2023

Aug 14, 2023

BUY
$2.15 - $3.49 $83,779 - $135,994
38,967 Added 694.48%
44,578 $102,000
Q1 2023

May 09, 2023

SELL
$1.99 - $2.68 $1,418 - $1,910
-713 Reduced 11.27%
5,611 $13,000
Q4 2022

Feb 10, 2023

SELL
$1.8 - $2.56 $23,517 - $33,446
-13,065 Reduced 67.38%
6,324 $12,000
Q3 2022

Nov 10, 2022

BUY
$1.94 - $3.43 $25,670 - $45,385
13,232 Added 214.91%
19,389 $46,000
Q2 2022

Aug 15, 2022

SELL
$1.31 - $2.69 $13,241 - $27,190
-10,108 Reduced 62.15%
6,157 $11,000
Q1 2022

May 12, 2022

BUY
$1.95 - $3.89 $16,738 - $33,391
8,584 Added 111.76%
16,265 $34,000
Q4 2021

Feb 14, 2022

SELL
$3.81 - $6.16 $27,885 - $45,085
-7,319 Reduced 48.79%
7,681 $30,000
Q3 2021

Nov 15, 2021

BUY
$3.38 - $5.35 $37,663 - $59,615
11,143 Added 288.9%
15,000 $73,000
Q2 2021

Aug 16, 2021

SELL
$4.12 - $5.87 $9,340 - $13,307
-2,267 Reduced 37.02%
3,857 $18,000
Q1 2021

May 17, 2021

SELL
$3.45 - $9.09 $3,412 - $8,990
-989 Reduced 13.9%
6,124 $36,000
Q4 2020

Feb 16, 2021

SELL
$1.05 - $3.67 $41,573 - $145,309
-39,594 Reduced 84.77%
7,113 $24,000
Q3 2020

Nov 16, 2020

BUY
$1.44 - $2.1 $38,777 - $56,550
26,929 Added 136.16%
46,707 $67,000
Q2 2020

Aug 13, 2020

BUY
$1.75 - $2.3 $34,611 - $45,489
19,778 New
19,778 $40,000
Q1 2020

May 15, 2020

SELL
$1.8 - $4.28 $7,792 - $18,528
-4,329 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$3.16 - $5.15 $13,679 - $22,294
4,329 New
4,329 $18,000
Q3 2019

Nov 05, 2019

SELL
$1.2 - $6.66 $111 - $619
-93 Closed
0 $0
Q2 2019

Aug 13, 2019

SELL
$5.35 - $7.11 $5,981 - $7,948
-1,118 Reduced 92.32%
93 $1,000
Q1 2019

May 14, 2019

SELL
$4.36 - $7.94 $2,977 - $5,423
-683 Reduced 36.06%
1,211 $7,000
Q4 2018

Feb 14, 2019

BUY
$6.15 - $10.51 $7,828 - $13,379
1,273 Added 204.99%
1,894 $13,000
Q3 2018

Nov 13, 2018

SELL
$10.32 - $13.06 $70,403 - $89,095
-6,822 Reduced 91.66%
621 $7,000
Q2 2018

Aug 15, 2018

BUY
$7.8 - $13.69 $54,280 - $95,268
6,959 Added 1437.81%
7,443 $89,000
Q1 2018

May 15, 2018

BUY
$7.86 - $11.39 $2,302 - $3,337
293 Added 153.4%
484 $4,000
Q4 2017

Feb 09, 2018

SELL
$8.77 - $12.28 $27,643 - $38,706
-3,152 Reduced 94.29%
191 $2,000
Q3 2017

Nov 14, 2017

BUY
$12.17 - $16.3 $40,684 - $54,490
3,343
3,343 $41,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $134M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.